<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00691925</url>
  </required_header>
  <id_info>
    <org_study_id>0164</org_study_id>
    <nct_id>NCT00691925</nct_id>
  </id_info>
  <brief_title>Mitigating Pain Following Refractive Surgery</brief_title>
  <official_title>Contact Lens for Mitigating Pain Following Refractive Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FORSIGHT Vision3</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FORSIGHT Vision3</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using Contact lens following refractive procedure to reduce pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients at day 1 following the procedure will be treated with a contact lens and assessed
      for pain at 1,2,4 hours and 1,3,5 days.

      prospective comparative study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">4</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>bilateral post refractive surgery subject</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        at least 10 subjects following refractive surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who underwent bilateral Refractive surgery for myopic correction.

          2. Age 18-60.

          3. Evidence of an epithelial defect.

          4. Patient complains of significant pain.

          5. Patients able to understand the requirements of the study and willing to follow study
             instructions, to provide written informed consent to participate, and who agree to
             comply with all study requirements, including the required study follow-up visits.

        Exclusion Criteria:

          1. Any other anterior segment abnormality other than that associated with Refractive
             surgery.

          2. Any abnormalities associated with the eye lids.

          3. Prior laser treatment of the retina.

          4. Any ophthalmic surgery performed within three (3) months prior to study excluding
             Refractive surgery.

          5. Diagnosis of glaucoma.

          6. Active diabetic retinopathy.

          7. Clinically significant inflammation or infection within six (6) months prior to study.

          8. Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of
             the Investigator.

          9. Participation in any study involving an investigational drug within the past 30
             calendar days, or ongoing participation in a study with an investigational material.

         10. Intolerance or hypersensitivity to topical anesthetics,

         11. Specifically known intolerance or hypersensitivity to contact lenses.

         12. A medical condition, serious intercurrent illness, or extenuating circumstance that
             would significantly decrease study compliance, including all prescribed follow-up.

         13. Any condition that, in the opinion of the investigator, would jeopardize the safety of
             the patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Verssano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sorasky Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sorasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2008</study_first_submitted>
  <study_first_submitted_qc>June 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2008</study_first_posted>
  <last_update_submitted>June 2, 2009</last_update_submitted>
  <last_update_submitted_qc>June 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Osnat Ehrman</name_title>
    <organization>FORSIGHT</organization>
  </responsible_party>
  <keyword>refractive surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

